Cargando…

Complications Following BellaGen™ Injection

BellaGen™ is an injectable acellular dermal matrix granule derived from donated human skin tissue that was recently developed for soft tissue augmentation. Its use has been sporadically reported in penile girth enhancement procedures. Many cases of complications have been reported after injecting ac...

Descripción completa

Detalles Bibliográficos
Autores principales: Park, Mi Kyung, Kim, Hyun Kyu, Park, Kui Young, Li, Kapsok, Seo, Seong Jun, Hong, Chang Kwun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Dermatological Association; The Korean Society for Investigative Dermatology 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3276783/
https://www.ncbi.nlm.nih.gov/pubmed/22346264
http://dx.doi.org/10.5021/ad.2011.23.S3.S306
_version_ 1782223403505156096
author Park, Mi Kyung
Kim, Hyun Kyu
Park, Kui Young
Li, Kapsok
Seo, Seong Jun
Hong, Chang Kwun
author_facet Park, Mi Kyung
Kim, Hyun Kyu
Park, Kui Young
Li, Kapsok
Seo, Seong Jun
Hong, Chang Kwun
author_sort Park, Mi Kyung
collection PubMed
description BellaGen™ is an injectable acellular dermal matrix granule derived from donated human skin tissue that was recently developed for soft tissue augmentation. Its use has been sporadically reported in penile girth enhancement procedures. Many cases of complications have been reported after injecting acellular dermal matrices like AlloDerm or SureDerm™ but few reports on complications associated with BellaGen™ injection. We report here on penile skin inflammation and necrosis following augmentation phalloplasty with BellaGen™, which developed 3 days after the injection and persisted for more than 2 weeks. The patient had a 15 year history of type 2 diabetes mellitus, and he was treated with oral antibiotics and wet dressings with KMNO4 solution to combine preservation of the remaining penile soft tissue with debridement of avascular tissue. The lesion improved with this treatment, but the patient experienced pain for about 2 weeks. All patients should be informed of the potential complications with the use of injectable acellular dermal matrices before treatment. Patient selection for augmentation is also important to have the most desirable results.
format Online
Article
Text
id pubmed-3276783
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher Korean Dermatological Association; The Korean Society for Investigative Dermatology
record_format MEDLINE/PubMed
spelling pubmed-32767832012-02-16 Complications Following BellaGen™ Injection Park, Mi Kyung Kim, Hyun Kyu Park, Kui Young Li, Kapsok Seo, Seong Jun Hong, Chang Kwun Ann Dermatol Case Report BellaGen™ is an injectable acellular dermal matrix granule derived from donated human skin tissue that was recently developed for soft tissue augmentation. Its use has been sporadically reported in penile girth enhancement procedures. Many cases of complications have been reported after injecting acellular dermal matrices like AlloDerm or SureDerm™ but few reports on complications associated with BellaGen™ injection. We report here on penile skin inflammation and necrosis following augmentation phalloplasty with BellaGen™, which developed 3 days after the injection and persisted for more than 2 weeks. The patient had a 15 year history of type 2 diabetes mellitus, and he was treated with oral antibiotics and wet dressings with KMNO4 solution to combine preservation of the remaining penile soft tissue with debridement of avascular tissue. The lesion improved with this treatment, but the patient experienced pain for about 2 weeks. All patients should be informed of the potential complications with the use of injectable acellular dermal matrices before treatment. Patient selection for augmentation is also important to have the most desirable results. Korean Dermatological Association; The Korean Society for Investigative Dermatology 2011-12 2011-12-27 /pmc/articles/PMC3276783/ /pubmed/22346264 http://dx.doi.org/10.5021/ad.2011.23.S3.S306 Text en Copyright © 2011 Korean Dermatological Association; The Korean Society for Investigative Dermatology http://creativecommons.org/licenses/by-nc/3.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Case Report
Park, Mi Kyung
Kim, Hyun Kyu
Park, Kui Young
Li, Kapsok
Seo, Seong Jun
Hong, Chang Kwun
Complications Following BellaGen™ Injection
title Complications Following BellaGen™ Injection
title_full Complications Following BellaGen™ Injection
title_fullStr Complications Following BellaGen™ Injection
title_full_unstemmed Complications Following BellaGen™ Injection
title_short Complications Following BellaGen™ Injection
title_sort complications following bellagen™ injection
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3276783/
https://www.ncbi.nlm.nih.gov/pubmed/22346264
http://dx.doi.org/10.5021/ad.2011.23.S3.S306
work_keys_str_mv AT parkmikyung complicationsfollowingbellageninjection
AT kimhyunkyu complicationsfollowingbellageninjection
AT parkkuiyoung complicationsfollowingbellageninjection
AT likapsok complicationsfollowingbellageninjection
AT seoseongjun complicationsfollowingbellageninjection
AT hongchangkwun complicationsfollowingbellageninjection